• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性心肌病与扩张型心肌病之间T细胞相关血清标志物的差异。

Differences in T cell-associated serum markers between ischemic cardiomyopathy and dilated cardiomyopathy.

作者信息

Huang Yuli, Xuan Lin, Xu Qiong, Wang Jun, Liu Jie

机构信息

Department of Cardiovascular Medicine, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.

Department of Internal Medicine, Suixi County Hospital of Traditional Chinese Medicine, Huaibei, China.

出版信息

J Thorac Dis. 2024 Jul 30;16(7):4655-4665. doi: 10.21037/jtd-24-901. Epub 2024 Jul 26.

DOI:10.21037/jtd-24-901
PMID:39144301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11320225/
Abstract

BACKGROUND

Ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) have similar clinical manifestations but differ in pathogenesis. We aimed to identify T cell-associated serum markers that can be used to distinguish between ICM and DCM.

METHODS

We identified differentially expressed genes (DEGs) with transcriptome sequencing data in GSE116250, and then conducted enrichment analysis of DEGs in the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. Protein-protein interaction (PPI) networks were used to analyze the relationship between T cells-related genes and identify hub genes. Enzyme-linked immunosorbent assay (ELISA) kits were used to detect T cell-associated proteins in serum, and receiver operating characteristic (ROC) curves were used to evaluate the diagnostic efficacy of these serum markers.

RESULTS

Using the limma package and Venn plots, we found that the non-failing donors (NFD) and DCM groups shared many of the same DEGs and DEGs-enriched functions compared to the ICM group, which were involved in T cell activation and differentiation, among other functions. Subsequently, the immune cell score showed no difference between NFD and DCM, but they were significantly different from ICM patients in CD8 T cells CD4 T cells memory resting and activated, T cells follicular helper, and M1 macrophage. After analyzing T cell-associated DEGs, it was found that 4 DEGs encoding secreted proteins were highly expressed in the ICM group compared with the NFD and DCM groups, namely chemokine (C-C motif) ligand 21 (), interleukin () lymphocyte-activation gene 3 (), and vascular cell adhesion molecule-1 (). Importantly, the serum levels of , , , and in ICM patients were all significantly higher than those in DCM patients. The ROC curves showed that the area under the curve (AUC) values of serum , , , and were 0.775, 0.868, 0.934, and 0.903, respectively.

CONCLUSIONS

We have identified four T cell-associated serum markers, , , , and , as potential diagnostic serum markers that differentiate ICM from DCM.

摘要

背景

缺血性心肌病(ICM)和扩张型心肌病(DCM)临床表现相似,但发病机制不同。我们旨在鉴定可用于区分ICM和DCM的T细胞相关血清标志物。

方法

我们利用GSE116250中的转录组测序数据鉴定差异表达基因(DEG),然后在基因本体论(GO)和京都基因与基因组百科全书(KEGG)数据库中对DEG进行富集分析。利用蛋白质-蛋白质相互作用(PPI)网络分析T细胞相关基因之间的关系并鉴定枢纽基因。使用酶联免疫吸附测定(ELISA)试剂盒检测血清中T细胞相关蛋白,并使用受试者工作特征(ROC)曲线评估这些血清标志物的诊断效能。

结果

使用limma软件包和维恩图,我们发现与ICM组相比,非衰竭供体(NFD)组和DCM组共享许多相同的DEG和DEG富集功能,这些功能涉及T细胞活化和分化等。随后,免疫细胞评分显示NFD和DCM之间无差异,但在CD8 T细胞、CD4 T细胞、静息和活化记忆T细胞、滤泡辅助性T细胞和M1巨噬细胞方面,它们与ICM患者有显著差异。在分析T细胞相关DEG后,发现与NFD组和DCM组相比,4个编码分泌蛋白的DEG在ICM组中高表达,即趋化因子(C-C基序)配体21()、白细胞介素()、淋巴细胞激活基因3()和血管细胞黏附分子1()。重要的是,ICM患者血清中、、和的水平均显著高于DCM患者。ROC曲线显示,血清、、和的曲线下面积(AUC)值分别为0.775、0.868、0.934和0.903。

结论

我们已鉴定出4种T细胞相关血清标志物、、和,作为区分ICM与DCM的潜在诊断血清标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/5b15c2b8a29b/jtd-16-07-4655-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/d6441cdc7791/jtd-16-07-4655-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/2d6220c0c7cd/jtd-16-07-4655-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/f1b08b1d6655/jtd-16-07-4655-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/9ea54a8046a3/jtd-16-07-4655-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/b121cd271ba9/jtd-16-07-4655-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/5b15c2b8a29b/jtd-16-07-4655-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/d6441cdc7791/jtd-16-07-4655-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/2d6220c0c7cd/jtd-16-07-4655-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/f1b08b1d6655/jtd-16-07-4655-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/9ea54a8046a3/jtd-16-07-4655-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/b121cd271ba9/jtd-16-07-4655-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1190/11320225/5b15c2b8a29b/jtd-16-07-4655-f6.jpg

相似文献

1
Differences in T cell-associated serum markers between ischemic cardiomyopathy and dilated cardiomyopathy.缺血性心肌病与扩张型心肌病之间T细胞相关血清标志物的差异。
J Thorac Dis. 2024 Jul 30;16(7):4655-4665. doi: 10.21037/jtd-24-901. Epub 2024 Jul 26.
2
Bioinformatics prediction of potential mechanisms and biomarkers underlying dilated cardiomyopathy.扩张型心肌病潜在机制和生物标志物的生物信息学预测
World J Cardiol. 2022 May 26;14(5):282-296. doi: 10.4330/wjc.v14.i5.282.
3
Bioinformatics Analysis and Identification of Genes and Pathways in Ischemic Cardiomyopathy.缺血性心肌病中基因和通路的生物信息学分析与鉴定
Int J Gen Med. 2021 Sep 21;14:5927-5937. doi: 10.2147/IJGM.S329980. eCollection 2021.
4
Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.人类心力衰竭转录组分析揭示扩张型心肌病中细胞黏附失调和缺血性心力衰竭中激活的免疫途径。
BMC Genomics. 2018 Nov 12;19(1):812. doi: 10.1186/s12864-018-5213-9.
5
Screening and identification of hub genes for ischemic cardiomyopathy and construction and validation of a clinical prognosis model using bioinformatics analysis.基于生物信息学分析的缺血性心肌病枢纽基因筛选与鉴定及临床预后模型的构建与验证
J Thorac Dis. 2024 Apr 30;16(4):2421-2431. doi: 10.21037/jtd-23-1722. Epub 2024 Apr 2.
6
Gene expression profiling reveals genes and transcription factors associated with dilated and ischemic cardiomyopathies.基因表达谱分析揭示了与扩张型和缺血性心肌病相关的基因和转录因子。
Pathol Res Pract. 2017 May;213(5):548-557. doi: 10.1016/j.prp.2016.12.017. Epub 2016 Dec 29.
7
Identification and Verification of Feature Biomarkers Associated With Immune Cells in Dilated Cardiomyopathy by Bioinformatics Analysis.通过生物信息学分析鉴定和验证扩张型心肌病中与免疫细胞相关的特征生物标志物
Front Genet. 2022 May 12;13:874544. doi: 10.3389/fgene.2022.874544. eCollection 2022.
8
Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics.代谢过程是区分非缺血性扩张型心肌病与缺血性心肌病的潜在生物学过程:来自血清蛋白质组学的线索
Pharmgenomics Pers Med. 2021 Sep 16;14:1169-1184. doi: 10.2147/PGPM.S323379. eCollection 2021.
9
m6A RNA methylation modification is involved in the disease course of heart failure.m6A RNA 甲基化修饰参与心力衰竭的疾病进程。
Biotechnol Genet Eng Rev. 2024 Oct;40(2):961-975. doi: 10.1080/02648725.2023.2191086. Epub 2023 Mar 21.
10
WGCNA combined with machine learning algorithms for analyzing key genes and immune cell infiltration in heart failure due to ischemic cardiomyopathy.加权基因共表达网络分析(WGCNA)结合机器学习算法用于分析缺血性心肌病所致心力衰竭中的关键基因和免疫细胞浸润
Front Cardiovasc Med. 2023 Mar 17;10:1058834. doi: 10.3389/fcvm.2023.1058834. eCollection 2023.

本文引用的文献

1
Ischemic cardiomyopathy: epidemiology, pathophysiology, outcomes, and therapeutic options.缺血性心肌病:流行病学、病理生理学、结局和治疗选择。
Heart Fail Rev. 2024 Jan;29(1):287-299. doi: 10.1007/s10741-023-10377-4. Epub 2023 Dec 16.
2
Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy.整合蛋白质组学分析揭示缺血性心肌病和扩张型心肌病中线粒体自噬的细胞骨架调控差异。
Mol Cell Proteomics. 2023 Dec;22(12):100667. doi: 10.1016/j.mcpro.2023.100667. Epub 2023 Oct 16.
3
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches.
扩张型心肌病:病因、发病机制及当前和未来的治疗方法。
Lancet. 2023 Sep 16;402(10406):998-1011. doi: 10.1016/S0140-6736(23)01241-2.
4
LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment.LIGHT/TNFSF14通过逆转免疫抑制性肿瘤微环境促进CAR-T细胞运输和细胞毒性。
Mol Ther. 2023 Sep 6;31(9):2575-2590. doi: 10.1016/j.ymthe.2023.06.015. Epub 2023 Jul 5.
5
T cell-extrinsic IL-1 signaling controls long-term gammaherpesvirus infection by suppressing viral reactivation.T 细胞外在的 IL-1 信号通过抑制病毒再激活来控制长期的γ疱疹病毒感染。
Virology. 2022 Nov;576:134-140. doi: 10.1016/j.virol.2022.09.006. Epub 2022 Oct 7.
6
Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes.糖尿病和非糖尿病衰竭人类心肌细胞中的钠-葡萄糖共转运蛋白 2 (SGLT2) 表达。
Pharmacol Res. 2022 Oct;184:106448. doi: 10.1016/j.phrs.2022.106448. Epub 2022 Sep 10.
7
Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction.缺血性心肌病和急性心肌梗死后心力衰竭。
Curr Cardiol Rep. 2022 Oct;24(10):1505-1515. doi: 10.1007/s11886-022-01766-6. Epub 2022 Aug 16.
8
Plasminogen and plasmin can bind to human T cells and generate truncated CCL21 that increases dendritic cell chemotactic responses.纤溶酶原和纤溶酶可以与人 T 细胞结合,并产生截短的 CCL21,从而增加树突状细胞的趋化反应。
J Biol Chem. 2022 Jul;298(7):102112. doi: 10.1016/j.jbc.2022.102112. Epub 2022 Jun 9.
9
Metabolic and Metabolomics Insights into Dilated Cardiomyopathy.扩张型心肌病的代谢与代谢组学见解
Ann Nutr Metab. 2022;78(3):147-155. doi: 10.1159/000524722. Epub 2022 Apr 26.
10
Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity.LAG-3与稳定的肽-主要组织相容性复合体II类的结合限制了T细胞功能,并抑制自身免疫和抗癌免疫。
Immunity. 2022 May 10;55(5):912-924.e8. doi: 10.1016/j.immuni.2022.03.013. Epub 2022 Apr 11.